Juan Sierra‐Madero

Author

Juan Sierra‐Madero

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán ORCID

Also Known As

César Rivera-Benitez, J G Sierra-Madero, J G. Sierra-Madero, J Sierra Madero, J Sierra-Madero, J. G. Sierra-Madero, J. Sierra-Madero, J. Sierra‐Madero, J.G. Sierra-Madero, Jaime-Federico Andrade-Villanueva

190

Publications

3.7K

Citations

H-Index

118

Concepts

All Affiliations

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Universidad Nacional Autónoma de México Fundacion Arriarán Vanderbilt University Fundación Huésped

About

Juan Sierra‐Madero is an author at Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	30	1.1K
2	Public Health	7	7	376
3	Health Sciences	5	5	179
4	Social Sciences	1	1	11
5	Cardiothoracic Surgery	1	1	26

Juan Sierra‐Madero

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
A Controlled Trial of Valganciclovir as Induction Therapy for Cytomegalovirus Retinitis Daniel Martín, Juan Sierra‐Madero, Sharon Walmsley, New England Journal of Medicine	2002	390
Effects of thalidomide on HIV-associated wasting syndrome: a randomized, double-blind, placebo-controlled clinical trial Gustavo Reyes‐Terán, Juan Sierra‐Madero, Veronica Martínez del Cerro, AIDS	1996	197
The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients Velia Ramírez‐Amador, Lilly Esquivel‐Pedraza, Juan Sierra‐Madero, Medicine Consecutive PatientsChanging Clinical SpectrumTreatment And PreventionKaposi SarcomaGlobal Health	2003	139
Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study Miguel García‐Grimshaw, Santa Elizabeth Ceballos‐Liceaga, Laura E. Hernández‐Vanegas, Clinical Immunology VaccinationVaccine SafetyVaccine DevelopmentVaccine SurveillanceVaccine Efficacy	2021	109
Clinical and Epidemiological Characteristics of Patients Diagnosed with COVID-19 in a Tertiary Care Center in Mexico City: A Prospective Cohort Study Edgar Ortíz‐Brizuela, Marco Villanueva-Reza, María Fernanda González-Lara, Revista de investigaci�n Cl�nica	2020	106
Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey Santiago Ávila‐Ríos, Claudia García‐Morales, Margarita Matías‐Florentino, The Lancet HIV Pretreatment Hiv-drug ResistanceWho SurveySubstance AbusePreventive MedicineRepresentative 2015	2016	103
High prevalence of late diagnosis of HIV in Mexico during the HAART era Brenda Crabtree‐Ramírez, Yanink Caro-Vega, Pablo F. Belaunzarán-Zamudio, Salud Pública de México	2012	81
Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1. Zahra Toossi, Juan Sierra‐Madero, Richard Blinkhorn, The Journal of Experimental Medicine	1993	79
Fulminant amebic colitis Takashi Takahashi, Armando Gamboa‐Domínguez, T J Gómez-Méndez, Diseases of the Colon & Rectum	1997	77
Cross-Sectional Analysis of Late HAART Initiation in Latin America and the Caribbean: Late Testers and Late Presenters Brenda Crabtree‐Ramírez, Yanink Caro-Vega, Bryan E. Shepherd, PLoS ONE	2011	73

Page 1